Faculty 2016–2017 Cycle 9

Washington, DC

The American Course on Drug Development and Regulatory Sciences (ACDRS) teaching faculty are science-driven and highly experienced international faculty members with a network of experts in pharmaceutical medicine, medical product development, and regulatory sciences.

Name Affiliation Location
Ramsey Baghdadi Prevision Policy Washington, DC
Robert Ball, MD, MPH, ScM US Food and Drug Administration Silver Spring, MD
Scott Berry, PhD Berry Consultants Austin, TX
Bruce S. Binkowitz, PhD Merck and Co., Inc. Rahway, NJ
Lauren Black, PhD Charles River Laboratories Baltimore, MD
Sir Alasdair Breckenridge, FRSE, FMedSci former MHRA chairman London, United Kingdom
Edward J. Calabrese, PhD, UMass Amherst Amherst, MA
Joseph C. Caminiti Publicis Healthcare Communications Group New York, NY
Louis R. Cantilena, MD, PhD Medical Strategic Initiatives, LLC Bethesda, MD
Emer Cooke, MBA World Health Organization Geneva, Switzerland
Tim Coté, MD, MPH Coté Orphan Consulting Washington, DC
Theodore Danoff, MD, PhD Clarus Therapeutics Philadelphia, PA
Patricia Evans, PhD Independent Consultant Los Altos, CA
David W. Feigal, Jr, MD, MPH Arizona State University School of Law San Francisco, CA
Dennis Fisher, MD The “P Less Than” Company San Francisco, CA
Leslie C. Floren, PharmD University of California, San Francisco San Francisco, CA
Michael J. Fossler, PharmD, PhD Trevena King of Prussia, PA
Joshua Galanter, MD University of California, San Francisco San Francisco, CA
Mark J. Goldberger, MD, MPH Consultant Washington, DC
Philip Goliber, PhD NDA Partners Canandaigua, NY
Charlie T. Gombar, PhD Bill and Melinda Gates Foundation Seattle, WA
Michael J. Gresser, PhD ImmunGene Los Angeles, CA
Charles Grudzinskas, PhD NDA Partners, LLC Annapolis, MD
Florence Houn, MD, MPH, FACP Celgene Washington, DC
John Jenkins, MD US Food and Drug Administration Silver Spring, MD
Diane K. Jorkasky, MD, FACP Complexa Inc. Philadelphia, PA
Kenneth Kaitin, PhD Tufts University Boston, MA
Amrita Kamath, PhD Genentech So San Francisco, CA
Jack Kloeber, PhD Kromite Philadelphia, PA
Paul Kluetz, MD US Food and Drug Administration Silver Spring, MD
Andy Lee Merck Research Laboratories Rahway, NJ
Christopher Lipinski, PhD Melior Discover Waterford, CT
Murray M. Lumpkin, MD, MSc Bill and Melinda Gates Foundation Seattle, WA
David Macarios, MBA Lifecell Corporation Bridgewater, NJ
Mark Noguchi, MBA Genentech So San Francisco, CA
Sally Okun, RN, MMHS PatientsLikeMe Cambridge, MA
Mary Thanh Hai, MD US Food and Drug Administration Silver Spring, MD
Lihua Pan Novartis Rockville, MD
Carl C. Peck, MD University of California, San Francisco San Luis Obispo, CA
Gene Pennello, PhD US Food and Drug Administration Silver Spring, MD
William Prucka Eli Lilly & Company Indianapolis, IN
Frank Rockhold, PhD Duke University Raleigh-Durham, NC
Malcolm Rowland, PhD, DSc University of California, San Francisco London, United Kingdom
Stephen J. Ruberg, PhD Eli Lilly and Company Indianapolis, IN
Hansjorg Sauer, MS, PhD, JD Biotechnology Industry Organization Washington, DC
Steven Shafer, MD Stanford University Stanford, CA
Jennifer Sims, PhD, ERT Integrated Biologix GmbH Basel, Switzerland
Vikram Sinha, PhD Merck and Co., Inc. Philadelphia, PA
Zachary Skrivanek Eli Lilly and Company Indianapolis, IN
Brian Smith, PhD Novartis Boston, MA
Dominic G. Spinella, PhD Amgen Thousand Oaks, CA
Peter Stein, MD US Food and Drug Administration Silver Spring, MD
S. Aubrey Stoch, MD Merck and Co., Inc. Rahway, NY
Toshiyoshi Tominaga, PhD Pharmaceuticals and Medical Devices Agency Tokyo, Japan
Paolo Vicini, PhD MedImmune Cambridge, UK
Theo Vos, MD, PhD University of Washington Seattle, WA
Yaning Wang, PhD US Food and Drug Administration Silver Spring, MD
John Warren, JD McDermott Will & Emery LLP Washington, DC

Faculty in other years

See Faculty.